Bill > S2285

This bill, called the "Uterine Cancer Study Act of 2025," directs the Secretary of Health and Human Services to conduct a comprehensive study on the potential link between chemical hair straighteners and uterine cancer, with a specific emphasis on understanding the impact on women of color. The study will review existing research findings, consider the effects across different racial and ethnic backgrounds, and analyze variations in hair straightening products that might include dyes, coloring, bleach, highlights, or perms. Within 45 days of the act's enactment, the Secretary must submit a detailed methodology description to key congressional committees, begin the study within 180 days, and complete a full report within two years of enactment. The study will also evaluate whether the Food and Drug Administration should implement additional safety testing requirements for hair straightening product manufacturers. By focusing on this specific health concern, the bill aims to better understand potential cancer risks associated with hair straightening products and provide recommendations for consumer safety.

Health and Social Services

https://www.congress.gov/bill/119th-congress/senate-bill/2285/all-info